{"transactions":[{"id":709762,"issuer":{"id":3735,"kind":"organization","name":"CG Oncology, Inc.","symbol":"CGON"},"owners":[{"id":30537,"kind":"person","name":"Mulay James","position":1,"cik":"0001684531","reported_name":"Mulay James","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (right to buy)","published_at":"2026-07-14T20:15:02.000Z","date":"2026-07-10","kind":"exercise","planned":true,"acquired":false,"shares":24165,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Fully vested."}],"balance_after":0,"derivative":{"exercise_price":26.63,"expiration_date":"2035-06-04","underlying":"Common Stock","underlying_shares":24165},"source":{"system":"sec-edgar","filing":"0001193125-26-303188","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1684531/000119312526303188/ownership.xml","form_type":"4"}},{"id":709761,"issuer":{"id":3735,"kind":"organization","name":"CG Oncology, Inc.","symbol":"CGON"},"owners":[{"id":30537,"kind":"person","name":"Mulay James","position":1,"cik":"0001684531","reported_name":"Mulay James","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-07-14T20:15:02.000Z","date":"2026-07-10","kind":"sale","planned":true,"acquired":false,"shares":24165,"price":75.16,"value":1816241.4,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 27, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $74.98 to $75.79 inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001193125-26-303188","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1684531/000119312526303188/ownership.xml","form_type":"4"}},{"id":709760,"issuer":{"id":3735,"kind":"organization","name":"CG Oncology, Inc.","symbol":"CGON"},"owners":[{"id":30537,"kind":"person","name":"Mulay James","position":1,"cik":"0001684531","reported_name":"Mulay James","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-07-14T20:15:02.000Z","date":"2026-07-10","kind":"exercise","planned":true,"acquired":true,"shares":24165,"price":26.63,"value":643513.95,"ownership":{"direct":true},"balance_after":24165,"source":{"system":"sec-edgar","filing":"0001193125-26-303188","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1684531/000119312526303188/ownership.xml","form_type":"4"}},{"id":736193,"issuer":{"id":3735,"kind":"organization","name":"CG Oncology, Inc.","symbol":"CGON"},"owners":[{"id":30537,"kind":"person","name":"Mulay James","position":1,"cik":"0001684531","reported_name":"Mulay James","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (right to buy)","published_at":"2026-06-16T21:07:09.000Z","date":"2026-06-15","kind":"exercise","planned":true,"acquired":false,"shares":1310,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The stock option vests in 36 substantially equal monthly installments beginning on January 13, 2024."}],"balance_after":2620,"derivative":{"exercise_price":12.59,"expiration_date":"2033-12-12","underlying":"Common Stock","underlying_shares":1310},"source":{"system":"sec-edgar","filing":"0001684531-26-000002","document":"form4-06162026_090604.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1684531/000168453126000002/form4-06162026_090604.xml","form_type":"4"}},{"id":736192,"issuer":{"id":3735,"kind":"organization","name":"CG Oncology, Inc.","symbol":"CGON"},"owners":[{"id":30537,"kind":"person","name":"Mulay James","position":1,"cik":"0001684531","reported_name":"Mulay James","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (right to buy)","published_at":"2026-06-16T21:07:09.000Z","date":"2026-06-15","kind":"exercise","planned":true,"acquired":false,"shares":654,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option vested in 36 substantially equal monthly installments beginning on July 14, 2023."}],"balance_after":0,"derivative":{"exercise_price":3.72,"expiration_date":"2033-06-13","underlying":"Common Stock","underlying_shares":654},"source":{"system":"sec-edgar","filing":"0001684531-26-000002","document":"form4-06162026_090604.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1684531/000168453126000002/form4-06162026_090604.xml","form_type":"4"}},{"id":736191,"issuer":{"id":3735,"kind":"organization","name":"CG Oncology, Inc.","symbol":"CGON"},"owners":[{"id":30537,"kind":"person","name":"Mulay James","position":1,"cik":"0001684531","reported_name":"Mulay James","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-16T21:07:09.000Z","date":"2026-06-15","kind":"sale","planned":true,"acquired":false,"shares":1310,"price":60.12,"value":78757.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 27, 2026."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001684531-26-000002","document":"form4-06162026_090604.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1684531/000168453126000002/form4-06162026_090604.xml","form_type":"4"}},{"id":736190,"issuer":{"id":3735,"kind":"organization","name":"CG Oncology, Inc.","symbol":"CGON"},"owners":[{"id":30537,"kind":"person","name":"Mulay James","position":1,"cik":"0001684531","reported_name":"Mulay James","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-16T21:07:09.000Z","date":"2026-06-15","kind":"exercise","planned":true,"acquired":true,"shares":1310,"price":12.59,"value":16492.9,"ownership":{"direct":true},"balance_after":1310,"source":{"system":"sec-edgar","filing":"0001684531-26-000002","document":"form4-06162026_090604.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1684531/000168453126000002/form4-06162026_090604.xml","form_type":"4"}},{"id":736189,"issuer":{"id":3735,"kind":"organization","name":"CG Oncology, Inc.","symbol":"CGON"},"owners":[{"id":30537,"kind":"person","name":"Mulay James","position":1,"cik":"0001684531","reported_name":"Mulay James","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-16T21:07:09.000Z","date":"2026-06-15","kind":"sale","planned":true,"acquired":false,"shares":654,"price":60.12,"value":39318.48,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 27, 2026."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001684531-26-000002","document":"form4-06162026_090604.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1684531/000168453126000002/form4-06162026_090604.xml","form_type":"4"}},{"id":736188,"issuer":{"id":3735,"kind":"organization","name":"CG Oncology, Inc.","symbol":"CGON"},"owners":[{"id":30537,"kind":"person","name":"Mulay James","position":1,"cik":"0001684531","reported_name":"Mulay James","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-16T21:07:09.000Z","date":"2026-06-15","kind":"exercise","planned":true,"acquired":true,"shares":654,"price":3.72,"value":2432.88,"ownership":{"direct":true},"balance_after":654,"source":{"system":"sec-edgar","filing":"0001684531-26-000002","document":"form4-06162026_090604.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1684531/000168453126000002/form4-06162026_090604.xml","form_type":"4"}},{"id":747941,"issuer":{"id":3735,"kind":"organization","name":"CG Oncology, Inc.","symbol":"CGON"},"owners":[{"id":30537,"kind":"person","name":"Mulay James","position":1,"cik":"0001684531","reported_name":"Mulay James","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (right to buy)","published_at":"2026-06-05T20:30:09.000Z","date":"2026-06-04","kind":"grant","planned":false,"acquired":true,"shares":9354,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/12th of the total number of shares of common stock subject to the option vest monthly following June 4, 2026, the date of grant (or, in the event the next annual meeting of the Issuer's stockholders occurs prior to the first anniversary of the date of grant, any remaining unvested portion of this stock option will vest on the date of such annual meeting of the Issuer's stockholders), subject to the Reporting Person's continuous service to the Issuer through each vesting date."}],"balance_after":9354,"derivative":{"exercise_price":56.09,"expiration_date":"2036-06-03","underlying":"Common Stock","underlying_shares":9354},"source":{"system":"sec-edgar","filing":"0001193125-26-259691","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1684531/000119312526259691/ownership.xml","form_type":"4"}},{"id":804465,"issuer":{"id":3735,"kind":"organization","name":"CG Oncology, Inc.","symbol":"CGON"},"owners":[{"id":30537,"kind":"person","name":"Mulay James","position":1,"cik":"0001684531","reported_name":"Mulay James","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (right to buy)","published_at":"2026-04-20T20:15:06.000Z","date":"2026-04-17","kind":"exercise","planned":true,"acquired":false,"shares":15600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Fully vested."}],"balance_after":0,"derivative":{"exercise_price":36.63,"expiration_date":"2034-10-03","underlying":"Common Stock","underlying_shares":15600},"source":{"system":"sec-edgar","filing":"0001193125-26-164013","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1684531/000119312526164013/ownership.xml","form_type":"4"}},{"id":804464,"issuer":{"id":3735,"kind":"organization","name":"CG Oncology, Inc.","symbol":"CGON"},"owners":[{"id":30537,"kind":"person","name":"Mulay James","position":1,"cik":"0001684531","reported_name":"Mulay James","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-04-20T20:15:06.000Z","date":"2026-04-17","kind":"sale","planned":true,"acquired":false,"shares":15600,"price":73.01,"value":1138956.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 6, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price.  These shares were sold in multiple transactions at prices ranging from $72.99 to $73.04, inclusive.  The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001193125-26-164013","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1684531/000119312526164013/ownership.xml","form_type":"4"}},{"id":804463,"issuer":{"id":3735,"kind":"organization","name":"CG Oncology, Inc.","symbol":"CGON"},"owners":[{"id":30537,"kind":"person","name":"Mulay James","position":1,"cik":"0001684531","reported_name":"Mulay James","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-04-20T20:15:06.000Z","date":"2026-04-17","kind":"exercise","planned":true,"acquired":true,"shares":15600,"price":36.63,"value":571428.0,"ownership":{"direct":true},"balance_after":15600,"source":{"system":"sec-edgar","filing":"0001193125-26-164013","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1684531/000119312526164013/ownership.xml","form_type":"4"}},{"id":837973,"issuer":{"id":3735,"kind":"organization","name":"CG Oncology, Inc.","symbol":"CGON"},"owners":[{"id":30537,"kind":"person","name":"Mulay James","position":1,"cik":"0001684531","reported_name":"Mulay James","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (right to buy)","published_at":"2026-03-17T20:15:05.000Z","date":"2026-03-16","kind":"exercise","planned":true,"acquired":false,"shares":1310,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The stock option vests in 36 substantially equal monthly installments beginning on January 13, 2024."}],"balance_after":3930,"derivative":{"exercise_price":12.59,"expiration_date":"2033-12-12","underlying":"Common Stock","underlying_shares":1310},"source":{"system":"sec-edgar","filing":"0001193125-26-110831","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1684531/000119312526110831/ownership.xml","form_type":"4"}},{"id":837972,"issuer":{"id":3735,"kind":"organization","name":"CG Oncology, Inc.","symbol":"CGON"},"owners":[{"id":30537,"kind":"person","name":"Mulay James","position":1,"cik":"0001684531","reported_name":"Mulay James","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (right to buy)","published_at":"2026-03-17T20:15:05.000Z","date":"2026-03-16","kind":"exercise","planned":true,"acquired":false,"shares":654,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option vests in 36 substantially equal monthly installments beginning on July 14, 2023."}],"balance_after":654,"derivative":{"exercise_price":3.72,"expiration_date":"2033-06-13","underlying":"Common Stock","underlying_shares":654},"source":{"system":"sec-edgar","filing":"0001193125-26-110831","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1684531/000119312526110831/ownership.xml","form_type":"4"}},{"id":837971,"issuer":{"id":3735,"kind":"organization","name":"CG Oncology, Inc.","symbol":"CGON"},"owners":[{"id":30537,"kind":"person","name":"Mulay James","position":1,"cik":"0001684531","reported_name":"Mulay James","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-03-17T20:15:05.000Z","date":"2026-03-16","kind":"sale","planned":true,"acquired":false,"shares":1310,"price":63.5,"value":83185.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 6, 2025."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001193125-26-110831","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1684531/000119312526110831/ownership.xml","form_type":"4"}},{"id":837970,"issuer":{"id":3735,"kind":"organization","name":"CG Oncology, Inc.","symbol":"CGON"},"owners":[{"id":30537,"kind":"person","name":"Mulay James","position":1,"cik":"0001684531","reported_name":"Mulay James","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-03-17T20:15:05.000Z","date":"2026-03-16","kind":"exercise","planned":true,"acquired":true,"shares":1310,"price":12.59,"value":16492.9,"ownership":{"direct":true},"balance_after":1310,"source":{"system":"sec-edgar","filing":"0001193125-26-110831","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1684531/000119312526110831/ownership.xml","form_type":"4"}},{"id":837969,"issuer":{"id":3735,"kind":"organization","name":"CG Oncology, Inc.","symbol":"CGON"},"owners":[{"id":30537,"kind":"person","name":"Mulay James","position":1,"cik":"0001684531","reported_name":"Mulay James","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-03-17T20:15:05.000Z","date":"2026-03-16","kind":"sale","planned":true,"acquired":false,"shares":654,"price":63.5,"value":41529.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 6, 2025."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001193125-26-110831","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1684531/000119312526110831/ownership.xml","form_type":"4"}},{"id":837968,"issuer":{"id":3735,"kind":"organization","name":"CG Oncology, Inc.","symbol":"CGON"},"owners":[{"id":30537,"kind":"person","name":"Mulay James","position":1,"cik":"0001684531","reported_name":"Mulay James","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-03-17T20:15:05.000Z","date":"2026-03-16","kind":"exercise","planned":true,"acquired":true,"shares":654,"price":3.72,"value":2432.88,"ownership":{"direct":true},"balance_after":654,"source":{"system":"sec-edgar","filing":"0001193125-26-110831","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1684531/000119312526110831/ownership.xml","form_type":"4"}},{"id":940071,"issuer":{"id":3735,"kind":"organization","name":"CG Oncology, Inc.","symbol":"CGON"},"owners":[{"id":30537,"kind":"person","name":"Mulay James","position":1,"cik":"0001684531","reported_name":"Mulay James","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (right to buy)","published_at":"2026-01-13T21:15:07.000Z","date":"2026-01-09","kind":"exercise","planned":true,"acquired":false,"shares":10491,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The stock option vests in 36 substantially equal monthly installments beginning on January 13, 2024."}],"balance_after":5240,"derivative":{"exercise_price":12.59,"expiration_date":"2033-12-12","underlying":"Common Stock","underlying_shares":10491},"source":{"system":"sec-edgar","filing":"0001193125-26-011756","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1684531/000119312526011756/ownership.xml","form_type":"4"}},{"id":940070,"issuer":{"id":3735,"kind":"organization","name":"CG Oncology, Inc.","symbol":"CGON"},"owners":[{"id":30537,"kind":"person","name":"Mulay James","position":1,"cik":"0001684531","reported_name":"Mulay James","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (right to buy)","published_at":"2026-01-13T21:15:07.000Z","date":"2026-01-09","kind":"exercise","planned":true,"acquired":false,"shares":654,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option vests in 36 substantially equal monthly installments beginning on July 14, 2023."}],"balance_after":1308,"derivative":{"exercise_price":3.72,"expiration_date":"2033-06-13","underlying":"Common Stock","underlying_shares":654},"source":{"system":"sec-edgar","filing":"0001193125-26-011756","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1684531/000119312526011756/ownership.xml","form_type":"4"}},{"id":940069,"issuer":{"id":3735,"kind":"organization","name":"CG Oncology, Inc.","symbol":"CGON"},"owners":[{"id":30537,"kind":"person","name":"Mulay James","position":1,"cik":"0001684531","reported_name":"Mulay James","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-01-13T21:15:07.000Z","date":"2026-01-09","kind":"sale","planned":true,"acquired":false,"shares":10491,"price":52.99,"value":555918.09,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 6, 2025."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001193125-26-011756","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1684531/000119312526011756/ownership.xml","form_type":"4"}},{"id":940068,"issuer":{"id":3735,"kind":"organization","name":"CG Oncology, Inc.","symbol":"CGON"},"owners":[{"id":30537,"kind":"person","name":"Mulay James","position":1,"cik":"0001684531","reported_name":"Mulay James","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-01-13T21:15:07.000Z","date":"2026-01-09","kind":"exercise","planned":true,"acquired":true,"shares":10491,"price":12.59,"value":132081.69,"ownership":{"direct":true},"balance_after":10491,"source":{"system":"sec-edgar","filing":"0001193125-26-011756","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1684531/000119312526011756/ownership.xml","form_type":"4"}},{"id":940067,"issuer":{"id":3735,"kind":"organization","name":"CG Oncology, Inc.","symbol":"CGON"},"owners":[{"id":30537,"kind":"person","name":"Mulay James","position":1,"cik":"0001684531","reported_name":"Mulay James","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-01-13T21:15:07.000Z","date":"2026-01-09","kind":"sale","planned":true,"acquired":false,"shares":654,"price":44.16,"value":28880.64,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 6, 2025."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001193125-26-011756","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1684531/000119312526011756/ownership.xml","form_type":"4"}},{"id":940066,"issuer":{"id":3735,"kind":"organization","name":"CG Oncology, Inc.","symbol":"CGON"},"owners":[{"id":30537,"kind":"person","name":"Mulay James","position":1,"cik":"0001684531","reported_name":"Mulay James","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-01-13T21:15:07.000Z","date":"2026-01-09","kind":"exercise","planned":true,"acquired":true,"shares":654,"price":3.72,"value":2432.88,"ownership":{"direct":true},"balance_after":654,"source":{"system":"sec-edgar","filing":"0001193125-26-011756","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1684531/000119312526011756/ownership.xml","form_type":"4"}},{"id":1020251,"issuer":{"id":3735,"kind":"organization","name":"CG Oncology, Inc.","symbol":"CGON"},"owners":[{"id":30537,"kind":"person","name":"Mulay James","position":1,"cik":"0001684531","reported_name":"Mulay James","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (right to buy)","published_at":"2025-10-10T20:15:03.000Z","date":"2025-10-09","kind":"exercise","planned":true,"acquired":false,"shares":5903,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option vests in 36 substantially equal monthly installments beginning on July 14, 2023."}],"balance_after":1962,"derivative":{"exercise_price":3.72,"expiration_date":"2033-06-13","underlying":"Common Stock","underlying_shares":5903},"source":{"system":"sec-edgar","filing":"0001193125-25-237104","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1684531/000119312525237104/ownership.xml","form_type":"4"}},{"id":1020250,"issuer":{"id":3735,"kind":"organization","name":"CG Oncology, Inc.","symbol":"CGON"},"owners":[{"id":30537,"kind":"person","name":"Mulay James","position":1,"cik":"0001684531","reported_name":"Mulay James","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-10-10T20:15:03.000Z","date":"2025-10-09","kind":"sale","planned":true,"acquired":false,"shares":5903,"price":43.99,"value":259672.97,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 6, 2025."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001193125-25-237104","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1684531/000119312525237104/ownership.xml","form_type":"4"}},{"id":1020249,"issuer":{"id":3735,"kind":"organization","name":"CG Oncology, Inc.","symbol":"CGON"},"owners":[{"id":30537,"kind":"person","name":"Mulay James","position":1,"cik":"0001684531","reported_name":"Mulay James","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-10-10T20:15:03.000Z","date":"2025-10-09","kind":"exercise","planned":true,"acquired":true,"shares":5903,"price":3.72,"value":21959.16,"ownership":{"direct":true},"balance_after":5903,"source":{"system":"sec-edgar","filing":"0001193125-25-237104","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1684531/000119312525237104/ownership.xml","form_type":"4"}},{"id":1030573,"issuer":{"id":3735,"kind":"organization","name":"CG Oncology, Inc.","symbol":"CGON"},"owners":[{"id":30537,"kind":"person","name":"Mulay James","position":1,"cik":"0001684531","reported_name":"Mulay James","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (right to buy)","published_at":"2025-09-30T20:38:28.000Z","date":"2025-09-29","kind":"exercise","planned":true,"acquired":false,"shares":12755,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Fully vested"}],"balance_after":0,"derivative":{"exercise_price":1.82,"expiration_date":"2031-07-18","underlying":"Common Stock","underlying_shares":12755},"source":{"system":"sec-edgar","filing":"0001193125-25-225133","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1684531/000119312525225133/ownership.xml","form_type":"4"}},{"id":1030572,"issuer":{"id":3735,"kind":"organization","name":"CG Oncology, Inc.","symbol":"CGON"},"owners":[{"id":30537,"kind":"person","name":"Mulay James","position":1,"cik":"0001684531","reported_name":"Mulay James","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-09-30T20:38:28.000Z","date":"2025-09-29","kind":"sale","planned":true,"acquired":false,"shares":12755,"price":39.19,"value":499868.45,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 6, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price.  These shares were sold in multiple transactions at prices ranging from $38.99 to $39.41, inclusive.  The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001193125-25-225133","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1684531/000119312525225133/ownership.xml","form_type":"4"}},{"id":1030571,"issuer":{"id":3735,"kind":"organization","name":"CG Oncology, Inc.","symbol":"CGON"},"owners":[{"id":30537,"kind":"person","name":"Mulay James","position":1,"cik":"0001684531","reported_name":"Mulay James","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-09-30T20:38:28.000Z","date":"2025-09-29","kind":"exercise","planned":true,"acquired":true,"shares":12755,"price":1.82,"value":23214.1,"ownership":{"direct":true},"balance_after":12755,"source":{"system":"sec-edgar","filing":"0001193125-25-225133","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1684531/000119312525225133/ownership.xml","form_type":"4"}},{"id":1034521,"issuer":{"id":3735,"kind":"organization","name":"CG Oncology, Inc.","symbol":"CGON"},"owners":[{"id":30537,"kind":"person","name":"Mulay James","position":1,"cik":"0001684531","reported_name":"Mulay James","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (right to buy)","published_at":"2025-09-22T11:30:03.000Z","date":"2025-09-19","kind":"exercise","planned":true,"acquired":false,"shares":3574,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Fully vested"}],"balance_after":12755,"derivative":{"exercise_price":1.82,"expiration_date":"2031-07-18","underlying":"Common Stock","underlying_shares":3574},"source":{"system":"sec-edgar","filing":"0001193125-25-210015","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1684531/000119312525210015/ownership.xml","form_type":"4"}},{"id":1034520,"issuer":{"id":3735,"kind":"organization","name":"CG Oncology, Inc.","symbol":"CGON"},"owners":[{"id":30537,"kind":"person","name":"Mulay James","position":1,"cik":"0001684531","reported_name":"Mulay James","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (right to buy)","published_at":"2025-09-22T11:30:03.000Z","date":"2025-09-18","kind":"exercise","planned":true,"acquired":false,"shares":19112,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Fully vested"}],"balance_after":16329,"derivative":{"exercise_price":1.82,"expiration_date":"2031-07-18","underlying":"Common Stock","underlying_shares":19112},"source":{"system":"sec-edgar","filing":"0001193125-25-210015","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1684531/000119312525210015/ownership.xml","form_type":"4"}},{"id":1034519,"issuer":{"id":3735,"kind":"organization","name":"CG Oncology, Inc.","symbol":"CGON"},"owners":[{"id":30537,"kind":"person","name":"Mulay James","position":1,"cik":"0001684531","reported_name":"Mulay James","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-09-22T11:30:03.000Z","date":"2025-09-19","kind":"sale","planned":true,"acquired":false,"shares":3574,"price":38.99,"value":139350.26,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 6, 2025."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001193125-25-210015","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1684531/000119312525210015/ownership.xml","form_type":"4"}},{"id":1034518,"issuer":{"id":3735,"kind":"organization","name":"CG Oncology, Inc.","symbol":"CGON"},"owners":[{"id":30537,"kind":"person","name":"Mulay James","position":1,"cik":"0001684531","reported_name":"Mulay James","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-09-22T11:30:03.000Z","date":"2025-09-19","kind":"exercise","planned":true,"acquired":true,"shares":3574,"price":1.82,"value":6504.68,"ownership":{"direct":true},"balance_after":3574,"source":{"system":"sec-edgar","filing":"0001193125-25-210015","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1684531/000119312525210015/ownership.xml","form_type":"4"}},{"id":1034517,"issuer":{"id":3735,"kind":"organization","name":"CG Oncology, Inc.","symbol":"CGON"},"owners":[{"id":30537,"kind":"person","name":"Mulay James","position":1,"cik":"0001684531","reported_name":"Mulay James","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-09-22T11:30:03.000Z","date":"2025-09-18","kind":"sale","planned":true,"acquired":false,"shares":19112,"price":39.01,"value":745559.12,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 6, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price.  These shares were sold in multiple transactions at prices ranging from $38.99 to $39.12, inclusive.  The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001193125-25-210015","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1684531/000119312525210015/ownership.xml","form_type":"4"}},{"id":1034516,"issuer":{"id":3735,"kind":"organization","name":"CG Oncology, Inc.","symbol":"CGON"},"owners":[{"id":30537,"kind":"person","name":"Mulay James","position":1,"cik":"0001684531","reported_name":"Mulay James","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-09-22T11:30:03.000Z","date":"2025-09-18","kind":"exercise","planned":true,"acquired":true,"shares":19112,"price":1.82,"value":34783.84,"ownership":{"direct":true},"balance_after":19112,"source":{"system":"sec-edgar","filing":"0001193125-25-210015","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1684531/000119312525210015/ownership.xml","form_type":"4"}},{"id":1045872,"issuer":{"id":3735,"kind":"organization","name":"CG Oncology, Inc.","symbol":"CGON"},"owners":[{"id":30537,"kind":"person","name":"Mulay James","position":1,"cik":"0001684531","reported_name":"Mulay James","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (right to buy)","published_at":"2025-09-08T20:16:22.000Z","date":"2025-09-05","kind":"exercise","planned":true,"acquired":false,"shares":27015,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Fully vested"}],"balance_after":0,"derivative":{"exercise_price":0.6,"expiration_date":"2028-07-08","underlying":"Common Stock","underlying_shares":27015},"source":{"system":"sec-edgar","filing":"0000950170-25-113556","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1684531/000095017025113556/ownership.xml","form_type":"4"}},{"id":1045871,"issuer":{"id":3735,"kind":"organization","name":"CG Oncology, Inc.","symbol":"CGON"},"owners":[{"id":30537,"kind":"person","name":"Mulay James","position":1,"cik":"0001684531","reported_name":"Mulay James","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-09-08T20:16:22.000Z","date":"2025-09-05","kind":"sale","planned":true,"acquired":false,"shares":3113,"price":33.22,"value":103413.86,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 6, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price.  These shares were sold in multiple transactions at prices ranging from $33.06 to $33.56, inclusive.  The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000950170-25-113556","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1684531/000095017025113556/ownership.xml","form_type":"4"}},{"id":1045870,"issuer":{"id":3735,"kind":"organization","name":"CG Oncology, Inc.","symbol":"CGON"},"owners":[{"id":30537,"kind":"person","name":"Mulay James","position":1,"cik":"0001684531","reported_name":"Mulay James","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-09-08T20:16:22.000Z","date":"2025-09-05","kind":"sale","planned":true,"acquired":false,"shares":7465,"price":32.64,"value":243657.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 6, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price.  These shares were sold in multiple transactions at prices ranging from $32.06 to $33.05, inclusive.  The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":3113,"source":{"system":"sec-edgar","filing":"0000950170-25-113556","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1684531/000095017025113556/ownership.xml","form_type":"4"}},{"id":1045869,"issuer":{"id":3735,"kind":"organization","name":"CG Oncology, Inc.","symbol":"CGON"},"owners":[{"id":30537,"kind":"person","name":"Mulay James","position":1,"cik":"0001684531","reported_name":"Mulay James","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-09-08T20:16:22.000Z","date":"2025-09-05","kind":"sale","planned":true,"acquired":false,"shares":4095,"price":31.42,"value":128664.9,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 6, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price.  These shares were sold in multiple transactions at prices ranging from $31.01 to $31.98, inclusive.  The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":10578,"source":{"system":"sec-edgar","filing":"0000950170-25-113556","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1684531/000095017025113556/ownership.xml","form_type":"4"}},{"id":1045868,"issuer":{"id":3735,"kind":"organization","name":"CG Oncology, Inc.","symbol":"CGON"},"owners":[{"id":30537,"kind":"person","name":"Mulay James","position":1,"cik":"0001684531","reported_name":"Mulay James","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-09-08T20:16:22.000Z","date":"2025-09-05","kind":"sale","planned":true,"acquired":false,"shares":12342,"price":30.47,"value":376060.74,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 6, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price.  These shares were sold in multiple transactions at prices ranging from $30.00 to $30.99, inclusive.  The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":14673,"source":{"system":"sec-edgar","filing":"0000950170-25-113556","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1684531/000095017025113556/ownership.xml","form_type":"4"}},{"id":1045867,"issuer":{"id":3735,"kind":"organization","name":"CG Oncology, Inc.","symbol":"CGON"},"owners":[{"id":30537,"kind":"person","name":"Mulay James","position":1,"cik":"0001684531","reported_name":"Mulay James","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-09-08T20:16:22.000Z","date":"2025-09-05","kind":"exercise","planned":true,"acquired":true,"shares":27015,"price":0.6,"value":16209.0,"ownership":{"direct":true},"balance_after":27015,"source":{"system":"sec-edgar","filing":"0000950170-25-113556","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1684531/000095017025113556/ownership.xml","form_type":"4"}},{"id":1119669,"issuer":{"id":3735,"kind":"organization","name":"CG Oncology, Inc.","symbol":"CGON"},"owners":[{"id":30537,"kind":"person","name":"Mulay James","position":1,"cik":"0001684531","reported_name":"Mulay James","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (right to buy)","published_at":"2025-06-06T21:00:28.000Z","date":"2025-06-05","kind":"grant","planned":true,"acquired":true,"shares":24165,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/12th of the total number of shares of common stock subject to the option vest monthly following June 5, 2025, the date of grant (or, in the event the next annual meeting of the Issuer's stockholders occurs prior to the first anniversary of the date of grant, any remaining unvested portion of this stock option will vest on the date of such annual meeting of the Issuer's stockholders), subject to the Reporting Person's continuous service to the Issuer through each vesting date."}],"balance_after":24165,"derivative":{"exercise_price":26.63,"expiration_date":"2035-06-04","underlying":"Common Stock","underlying_shares":24165},"source":{"system":"sec-edgar","filing":"0000950170-25-083238","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1684531/000095017025083238/ownership.xml","form_type":"4"}},{"id":1390121,"issuer":{"id":3735,"kind":"organization","name":"CG Oncology, Inc.","symbol":"CGON"},"owners":[{"id":30537,"kind":"person","name":"Mulay James","position":1,"cik":"0001684531","reported_name":"Mulay James","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-10-07T21:00:44.000Z","date":"2024-10-04","kind":"grant","planned":false,"acquired":true,"shares":15600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/12th of the total number of shares of common stock subject to the option vest monthly following October 4, 2024, the date of grant, subject to the Reporting Person's continuous service to the Issuer through each vesting date."}],"balance_after":15600,"derivative":{"exercise_price":36.63,"expiration_date":"2034-10-03","underlying":"Common Stock","underlying_shares":15600},"source":{"system":"sec-edgar","filing":"0000950170-24-113299","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1684531/000095017024113299/ownership.xml","form_type":"4"}},{"id":3504765,"issuer":{"id":2545,"kind":"organization","name":"Fulgent Genetics, Inc.","symbol":"FLGT"},"owners":[{"id":30537,"kind":"person","name":"Mulay James","position":1,"cik":"0001684531","reported_name":"Mulay James","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-06-03T20:07:55.000Z","date":"2019-05-30","kind":"grant","acquired":true,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option vest over a period of four years, with 1/4th of such shares vesting 12 months after May 30, 2019, and 1/16th of such shares  vesting at the end of every three-month period over the 36 months thereafter, subject to Dr. Mulay's continued service for the Issuer on each vesting date."}],"balance_after":5000,"derivative":{"exercise_price":5.8098,"expiration_date":"2029-05-30","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001209191-19-033858","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1684531/000120919119033858/doc4.xml","form_type":"4"}},{"id":3924117,"issuer":{"id":2545,"kind":"organization","name":"Fulgent Genetics, Inc.","symbol":"FLGT"},"owners":[{"id":30537,"kind":"person","name":"Mulay James","position":1,"cik":"0001684531","reported_name":"Mulay James","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2018-05-21T20:06:09.000Z","date":"2018-05-18","kind":"grant","acquired":true,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option vest over a period of four years, with 1/4th of such shares vesting 12 months after May 18, 2018, and 1/16th of such shares vesting at the end of every three-month period over the 36 months thereafter, subject to Dr. Mulay's continued service for the Issuer on each vesting date."}],"balance_after":5000,"derivative":{"exercise_price":3.925,"expiration_date":"2028-05-18","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001209191-18-031806","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1684531/000120919118031806/doc4.xml","form_type":"4"}},{"id":4285711,"issuer":{"id":2545,"kind":"organization","name":"Fulgent Genetics, Inc.","symbol":"FLGT"},"owners":[{"id":30537,"kind":"person","name":"Mulay James","position":1,"cik":"0001684531","reported_name":"Mulay James","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-06-13T00:24:58.000Z","date":"2017-05-16","kind":"grant","acquired":true,"shares":2000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents an award of 2,000 restricted stock units (\"RSUs\") granted to Dr. Mulay in connection with his reelection as a director of the Issuer. Each RSU represents the contingent right to receive one share of the Issuer's common stock. The RSUs vest over a period of four years, with 1/4th of the shares subject to the RSUs vesting 12 months after May 16, 2017, and 1/16th of the remaining shares subject to the RSUs vesting at the end of every three-month period over the 36 months thereafter, subject to Dr. Mulay's continued service for the Issuer on each vesting date."},{"field":"shares","element":"transactionShares","label":"F2","text":"This amendment is being filed because the name of the reporting person was incorrect in the Form 4 as originally filed. This line item is being re-reported in this amendment in order to gain access to the filing system for purposes of filing this amendment."}],"balance_after":10000,"source":{"system":"sec-edgar","filing":"0001209191-17-039312","document":"doc4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1684531/000120919117039312/doc4a.xml","form_type":"4/A","original_submission_date":"2017-05-18"}},{"id":4572972,"issuer":{"id":2545,"kind":"organization","name":"Fulgent Genetics, Inc.","symbol":"FLGT"},"owners":[{"id":30537,"kind":"person","name":"Mulay James","position":1,"cik":"0001684531","reported_name":"Mulay James","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2016-10-28T20:16:49.000Z","date":"2016-10-26","kind":"grant","acquired":true,"shares":8000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents an award of 8,000 restricted stock units (\"RSUs\") granted to Dr. Mulay in connection with his appointment as a director of the Issuer. Each RSU represents the contingent right to receive one share of the Issuer's common stock. The RSUs vest over a period of four years, with 1/4th of the shares subject to the RSUs vesting 12 months after September 28, 2016, and 1/16th of the remaining shares subject to the RSUs vesting at the end of every three-month period over the 36 months thereafter, subject to Dr. Mulay's continued service for the Issuer on each vesting date."}],"balance_after":8000,"source":{"system":"sec-edgar","filing":"0001209191-16-147291","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1684531/000120919116147291/doc4.xml","form_type":"4"}}]}